C07D 231/00
Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
C07D231/00 (Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings) appears on 10,684 US grants and 8,102 published applications in this corpus.
Search patents in C07D- Granted patents
- 10,684
- Published applications
- 8,102
- Assignees
- 2,618
- Inventors
- 23,039
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 148 | 0 |
| 1977 | 114 | 0 |
| 1978 | 133 | 0 |
| 1979 | 83 | 0 |
| 1980 | 128 | 0 |
| 1981 | 117 | 0 |
| 1982 | 123 | 0 |
| 1983 | 118 | 0 |
| 1984 | 132 | 0 |
| 1985 | 194 | 0 |
| 1986 | 185 | 0 |
| 1987 | 161 | 0 |
| 1988 | 197 | 0 |
| 1989 | 268 | 0 |
| 1990 | 277 | 0 |
| 1991 | 233 | 0 |
| 1992 | 224 | 0 |
| 1993 | 221 | 0 |
| 1994 | 161 | 0 |
| 1995 | 193 | 0 |
| 1996 | 233 | 0 |
| 1997 | 247 | 0 |
| 1998 | 236 | 0 |
| 1999 | 258 | 0 |
| 2000 | 238 | 0 |
| 2001 | 234 | 43 |
| 2002 | 300 | 258 |
| 2003 | 264 | 348 |
| 2004 | 177 | 499 |
| 2005 | 209 | 406 |
| 2006 | 233 | 325 |
| 2007 | 233 | 383 |
| 2008 | 209 | 371 |
| 2009 | 261 | 397 |
| 2010 | 283 | 427 |
| 2011 | 270 | 344 |
| 2012 | 318 | 307 |
| 2013 | 292 | 315 |
| 2014 | 280 | 310 |
| 2015 | 275 | 324 |
| 2016 | 268 | 371 |
| 2017 | 304 | 330 |
| 2018 | 254 | 320 |
| 2019 | 230 | 273 |
| 2020 | 230 | 297 |
| 2021 | 188 | 284 |
| 2022 | 173 | 260 |
| 2023 | 167 | 304 |
| 2024 | 147 | 237 |
| 2025 | 154 | 215 |
| 2026 | 109 | 154 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Stable pharmaceutical compositions of edaravone and dextrocamphol6 Oct 2026US 12,751,941 B2Jiangsu Simcere Pharmaceutical Co., Ltd.
- Pyrazole compounds for organic light emitting diodes and other applications6 Oct 2026US 12,757,631 B2Kebotix, Inc.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Pyrazolyl compounds as KV7 channel activators29 Sep 2026US 12,747,237 B2
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Prodrugs of myc inhibitors8 Oct 2026US 2026/0308129 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Compound containing oxo-pyrido-aliphatic ring or aliphatic heterocyclic structure, and medical use thereof8 Oct 2026US 2026/0308164 A1Sichuan Purity Pharmaceutical Co., Ltd.
- Sulphonamide compounds1 Oct 2026US 2026/0297056 A1Anaxis Pharma Pty Ltd
- Organic electroluminescent element and electronic device1 Oct 2026US 2026/0297107 A1Idemitsu Kosan Co., Ltd.
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Most cited
By later US patents
- Phenyl and fluorenyl substituted phenyl-pyrazole complexes of Ir897US 7,338,722 B2University of Southern California · 2008
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010
- Oxidation hair dye composition containinng diaminopyrazol derivatives and new diaminopyrazol derivatives423US 5,061,289 AWella Aktiengesellschaft · 1991
- Alkynyl and azido-substituted 4-anilinoquinazolines379US 5,747,498 APfizer Inc. · 1998